Additional Option Grant. You will be granted an option (the “Option”) to purchase 85,000 shares of common stock of the Company, with an exercise price equal to the fair market value of the common stock on the grant date, and with one-third of the Option vesting on December 31, 2021, and the other two-thirds vesting on December 31, 2022. The Option will be evidenced by a standard stock option agreement, and will be subject to the terms and conditions of that agreement and the Plan.
Appears in 4 contracts
Samples: Retention Benefits Agreement (Minerva Neurosciences, Inc.), Retention Benefits Agreement (Minerva Neurosciences, Inc.), Retention Benefits Agreement (Minerva Neurosciences, Inc.)
Additional Option Grant. You will be granted an option (the “Option”) to purchase 85,000 140,000 shares of common stock of the Company, with an exercise price equal to the fair market value of the common stock on the grant date, and with one-third of the Option vesting on December 31, 2021, and the other two-thirds vesting on December 31, 2022. The Option will be evidenced by a standard stock option agreement, and will be subject to the terms and conditions of that agreement and the Plan.
Appears in 1 contract
Samples: Retention Benefits Agreement (Minerva Neurosciences, Inc.)
Additional Option Grant. You will be granted an option (the “Option”) to purchase 85,000 200,000 shares of common stock of the Company, with an exercise price equal to the fair market value of the common stock on the grant date, and with one-third of the Option vesting on December 31, 2021, and the other two-thirds vesting on December 31, 2022. The Option will be evidenced by a standard stock option agreement, and will be subject to the terms and conditions of that agreement and the Plan.
Appears in 1 contract
Samples: Retention Benefits Agreement (Minerva Neurosciences, Inc.)
Additional Option Grant. You will be granted an option (the “Option”) to purchase 85,000 100,000 shares of common stock of the Company, with an exercise price equal to the fair market value of the common stock on the grant date, and with one-third of the Option vesting on December 31, 2021, and the other two-thirds vesting on December 31, 2022. The Option will be evidenced by a standard stock option agreement, and will be subject to the terms and conditions of that agreement and the Plan.
Appears in 1 contract
Samples: Retention Benefits Agreement (Minerva Neurosciences, Inc.)